The Korean journal of internal medicine

  • 제29권5호
  • /
  • Pages.647-655
  • /
  • 2014
  • /
  • 1226-3303(pISSN)
  • /
  • 2005-6648(eISSN)
대한내과학회 (The Korean Association of Internal Medicine)
권호 표지
DOI QR코드

DOI QR Code

SKI306X inhibition of glycosaminoglycan degradation in human cartilage involves down-regulation of cytokine-induced catabolic genes

  • Choi, Choong Hyeok (Department of Surgery for Rheumatism, Hanyang University Hospital for Rheumatic Diseases) ;
  • Kim, Tae-Hwan (Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases) ;
  • Sung, Yoon-Kyoung (Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases) ;
  • Choi, Chan-Bum (Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases) ;
  • Na, Young-In (Institute of Rheumatism, Hanyang University College of Medicine) ;
  • Yoo, Hunseung (Life Science R&D Center, SK Chemicals) ;
  • Jun, Jae-Bum (Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases)
  • 투고 : 2013.03.23
  • 심사 : 2013.09.25
  • 발행 : 2014.09.01
⟨ 이전 논문 다음 논문 ⟩

초록

Background/Aims: SKI306X, a mixed extract of three herbs, Clematis mandshurica (CM), Prunella vulgaris (PV), and Trichosanthes kirilowii (TK), is chondroprotective in animal models of osteoarthritis (OA). The objectives of this study were to investigate its effect on interleukin (IL)-$1{\beta}$-induced degradation of glycosaminoglycan (GAG) and the basis of its action in human OA cartilage, as well as to screen for the presence of inhibitors of matrix metalloproteinase (MMP)-13 and a disintegrin and metalloprotease with thrombospondin motifs (ADAMTS)-4 in SKI306X and its component herbs, as well as in fractions from SKI306X. Methods: Human OA chondrocytes and cartilage explants were obtained during total knee replacements and incubated with IL-$1{\beta}{\pm}$ oncostatin M with or without SKI306X or its component herb extracts. GAG degradation was assayed in cartilage explants using a commercial kit. Expression of genes involved in cartilage destruction was measured by real-time polymerase chain reaction using chondrocyte RNA. SKI306X was fractionated by preparative liquid chromatography to test for the presence of inhibitors of MMP-13 and ADAMTS-4. Results: SKI306X and PV inhibited IL-$1{\beta}$-induced GAG release from cartilage explants, and SKI306X, CM, PV, and TK inhibited IL-$1{\beta}$-induced MMP gene expression. Unexpectedly, SKI306X greatly stimulated IL-$1{\beta}$ + oncostatin M-induced ADAMTS-4 gene expression, probably due to its TK component. Some fractions of SKI306X also inhibited ADAMTS-4 activity. Conclusions: SKI306X and its herbal components inhibit GAG degradation and catabolic gene expression in human OA chondrocytes and cartilage explants. SKI306X likely also contains one or more ADAMTS-4 inhibitor.

키워드

과제정보

연구 과제 주관 기관 : Hanyang University

참고문헌

  1. Issa SN, Sharma L. Epidemiology of osteoarthritis: an update. Curr Rheumatol Rep 2006;8:7-15. https://doi.org/10.1007/s11926-006-0019-1
  2. Martel-Pelletier J, Boileau C, Pelletier JP, Roughley PJ. Cartilage in normal and osteoarthritis conditions. Best Pract Res Clin Rheumatol 2008;22:351-384. https://doi.org/10.1016/j.berh.2008.02.001
  3. Goldring SR, Goldring MB. The role of cytokines in cartilage matrix degeneration in osteoarthritis. Clin Orthop Relat Res 2004;(427 Suppl):S27-S36.
  4. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum 2000;43:1905-1915. https://doi.org/10.1002/1529-0131(200009)43:9<1905::AID-ANR1>3.0.CO;2-P
  5. Cameron M, Gagnier JJ, Little CV, Parsons TJ, Blumle A, Chrubasik S. Evidence of effectiveness of herbal medicinal products in the treatment of arthritis. Part I: osteoarthritis. Phytother Res 2009;23:1497-1515. https://doi.org/10.1002/ptr.3007
  6. Choi JH, Choi JH, Kim DY, et al. Effects of SKI 306X, a new herbal agent, on proteoglycan degradation in cartilage explant culture and collagenase-induced rabbit osteoarthritis model. Osteoarthritis Cartilage 2002;10:471-478. https://doi.org/10.1053/joca.2002.0526
  7. Kim JH, Ryu KH, Jung KW, Han CK, Kwak WJ, Cho YB. SKI306X suppresses cartilage destruction and inhibits the production of matrix metalloproteinase in rabbit joint cartilage explant culture. J Pharmacol Sci 2005;98:298-306. https://doi.org/10.1254/jphs.FPJ04058X
  8. Hartog A, Hougee S, Faber J, et al. The multicomponent phytopharmaceutical SKI306X inhibits in vitro cartilage degradation and the production of inflammatory mediators. Phytomedicine 2008;15:313-320. https://doi.org/10.1016/j.phymed.2007.09.005
  9. Jung YB, Roh KJ, Jung JA, et al. Effect of SKI 306X, a new herbal anti-arthritic agent, in patients with osteoarthritis of the knee: a double-blind placebo controlled study. Am J Chin Med 2001;29:485-491. https://doi.org/10.1142/S0192415X01000502
  10. Lung YB, Seong SC, Lee MC, et al. A four-week, randomized, double-blind trial of the efficacy and safety of SKI306X: a herbal anti-arthritic agent versus diclofenac in osteoarthritis of the knee. Am J Chin Med 2004;32:291-301. https://doi.org/10.1142/S0192415X04001941
  11. Billinghurst RC, Dahlberg L, Ionescu M, et al. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest 1997;99:1534-1545. https://doi.org/10.1172/JCI119316
  12. Song YW, Lee EY, Koh EM, et al. Assessment of comparative pain relief and tolerability of SKI306X compared with celecoxib in patients with rheumatoid arthritis: a 6-week, multicenter, randomized, double-blind, double- dummy, phase III, noninferiority clinical trial. Clin Ther 2007;29:862-873. https://doi.org/10.1016/j.clinthera.2007.05.006
  13. Uitterlinden EJ, Jahr H, Koevoet JL, et al. Glucosamine decreases expression of anabolic and catabolic genes in human osteoarthritic cartilage explants. Osteoarthritis Cartilage 2006;14:250-257. https://doi.org/10.1016/j.joca.2005.10.001
  14. Koshy PJ, Lundy CJ, Rowan AD, et al. The modulation of matrix metalloproteinase and ADAM gene expression in human chondrocytes by interleukin-1 and oncostatin M: a time-course study using real-time quantitative reverse transcription-polymerase chain reaction. Arthritis Rheum 2002;46:961-967. https://doi.org/10.1002/art.10212
  15. Wachsmuth L, Bau B, Fan Z, Pecht A, Gerwin N, Aigner T. ADAMTS-1, a gene product of articular chondrocytes in vivo and in vitro, is downregulated by interleukin 1beta. J Rheumatol 2004;31:315-320.
  16. Rogerson FM, Chung YM, Deutscher ME, Last K, Fosang AJ. Cytokine-induced increases in ADAMTS-4 messenger RNA expression do not lead to increased aggrecanase activity in ADAMTS-5-deficient mice. Arthritis Rheum 2010;62:3365-3373. https://doi.org/10.1002/art.27661
  17. Lauer-Fields JL, Spicer TP, Chase PS, et al. Screening of potential a disintegrin and metalloproteinase with thrombospondin motifs-4 inhibitors using a collagen model fluorescence resonance energy transfer substrate. Anal Biochem 2008;373:43-51. https://doi.org/10.1016/j.ab.2007.09.014
  18. Fosang AJ, Little CB. Drug insight: aggrecanases as therapeutic targets for osteoarthritis. Nat Clin Pract Rheumatol 2008;4:420-427.
  19. Lauer-Fields JL, Minond D, Chase PS, et al. High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate. Bioorg Med Chem 2009;17:990-1005. https://doi.org/10.1016/j.bmc.2008.03.004
  20. Li NG, Shi ZH, Tang YP, et al. New hope for the treatment of osteoarthritis through selective inhibition of MMP-13. Curr Med Chem 2011;18:977-1001. https://doi.org/10.2174/092986711794940905
  21. Verma P, Dalal K. ADAMTS-4 and ADAMTS-5: key enzymes in osteoarthritis. J Cell Biochem 2011;112:3507-3514. https://doi.org/10.1002/jcb.23298

피인용 문헌

  1. Anticancer Chemodiversity of Ranunculaceae Medicinal Plants: Molecular Mechanisms and Functions vol.18, pp.1, 2014, https://doi.org/10.2174/1389202917666160803151752
  2. Efficacy of JOINS on Cartilage Protection in Knee Osteoarthritis: Prospective Randomized Controlled Trial vol.29, pp.3, 2014, https://doi.org/10.5792/ksrr.17.004
  3. Comparison of pharmacokinetics and safety of fixed-dose combination of SKI306X and aceclofenac versus separate tablets in healthy subjects vol.25, pp.4, 2014, https://doi.org/10.12793/tcp.2017.25.4.196
  4. Polar extract of Curcuma longa protects cartilage homeostasis: possible mechanism of action vol.26, pp.5, 2018, https://doi.org/10.1007/s10787-017-0433-1
  5. Pharmaceutical therapeutics for articular regeneration and restoration: state-of-the-art technology for screening small molecular drugs vol.78, pp.24, 2014, https://doi.org/10.1007/s00018-021-03983-8